Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
12/2008
12/04/2008WO2008145740A1 Method for the production of n-substituted (3-dihalomethyl-1-methyl-pyrazole-4-yl) carboxamides
12/04/2008WO2008145681A2 Ccr2 receptor antagonists and uses thereof
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008WO2008145257A1 Process for the production of pyrazoles
12/04/2008WO2008080504A3 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
12/04/2008US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders
12/04/2008US20080300255 Substituted pyrazoles
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008CA2687931A1 Ccr2 receptor antagonists and uses thereof
12/04/2008CA2687176A1 Process for the production of pyrazoles
12/04/2008CA2686659A1 Method for the production of n-substituted (3-dihalomethyl-1-methylpyrazol-4-yl)carboxamides
12/04/2008CA2686651A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997808A1 Process for the production of pyrazoles
12/03/2008EP1997807A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
12/03/2008EP1997800A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996554A1 Sigma receptor inhibitors
12/03/2008CN101316818A 3-amino-1-arylpropyl indoles and aza-substituted indoles
12/03/2008CN101314591A Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent
12/03/2008CN100439341C Indazole derivatives as CRF antagonists
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/02/2008US7459564 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
12/02/2008US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides
12/02/2008US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
12/02/2008US7459414 Herbicides
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144275A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/27/2008WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
11/27/2008WO2008141976A1 Diacylglycerol acyltransferase inhibitors
11/27/2008WO2008141385A1 Viral polymerase inhibitors
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008US20080293936 Novel inhibitors of lysyl oxidase
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080292792 Azo Compound, Ink Composition, and Colored Object
11/27/2008CA2686951A1 Diacylglycerol acyltransferase inhibitors
11/27/2008CA2684764A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994008A2 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008CN101312952A Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/26/2008CN101312951A Heterocyclic compound possessing ó± type 11 beta-hydroxy steroid dehydrogenase inhibiting activity
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312724A Tetrahydro-indazolyl cannabinoid modulators
11/25/2008US7456295 Bis(thienyl)isopyrazoles and process for preparing and method for using bis(thienyl)isopyrazoles
11/25/2008US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility
11/25/2008US7456133 Substituted arylketones
11/25/2008US7455698 4-(Pyrazol-4-ylimino)-2,5-cyclohexadienylidene quaternary ammonium salts; oxidation color dyes, pyrazole dyes, and hair dyes; intense blue; colorfastness, washfastness, storage stability, water solubility
11/25/2008CA2275635C Pesticidal 1-arylpyrazoles
11/20/2008WO2008140338A1 New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses
11/20/2008WO2008138876A1 Pyrazole derivatives as p2x7 modulators
11/20/2008WO2008109697A3 Ppar active compounds
11/20/2008WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators
11/20/2008WO2007102883A3 Chemical compounds
11/20/2008US20080287681 Substituted Benzimidazoles and their Use for Inducing Apoptosis
11/20/2008US20080287676 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287516 Phenyl-Substituted Pyrrolidones
11/20/2008US20080287506 Insecticidal N,N-Di(Heteroarylalkyl) Amine Derivatives
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080286810 Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease
11/19/2008EP1992623A1 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
11/19/2008EP1992617A1 Optically active ethyl amides
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1991525A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives
11/19/2008CN101309907A Process for the production of carboxanilides
11/19/2008CN101307022A Green synthetic method for methyl-3-ethyl-4-chlorin-5-pyrazol formyl chloride
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008US7452997 Tetrahydro-indazole cannabinoid modulators
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452899 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/13/2008WO2008137408A1 Pyrazole inhibitors of wnt signaling
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135824A1 Oxyalkylpyrazole compounds useful in therapy
11/13/2008WO2008134970A1 Anthranilamide compounds and the use thereof
11/13/2008WO2008134969A1 Benzamide compounds and applications thereof
11/13/2008WO2008113760A3 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
11/13/2008WO2007131219A3 Cannabinoid receptor antagonists/inverse agonists
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 256